Thursday, May 30, 2019

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug The company said it has reached a settlement agreement with Onyx Therapeutics Inc related to generic versions of 10mg, 30mg and 60mg of Kyprolis.

from Moneycontrol Business News http://bit.ly/2Kc0mlT

No comments:

Post a Comment

Adani Group stocks slide up to 14% on US SEC heat

Adani Group stocks saw a sharp decline on Friday. This followed news that the US SEC is seeking court permission to email summons to founder...